Kent Lake Partners LP is an investment fund founded by Ben Natter in 2019 with a focus on small and mid-capitalization public equities, particularly in the healthcare space.

Mr. Natter has over a decade of successful public healthcare equity investing experience.

Kent Lake initially invested in Quanterix in 2022 and is currently a top three shareholder, owning 8% of the Company’s outstanding common stock.

We invested in Quanterix after conducting a rigorous analysis of the Company, including its balance sheet, capital structure, management agreements, portfolio, and market opportunities. We have strong conviction in the company’s potential, particularly in its Alzheimer’s diagnostic tests, to drive substantial value creation in the coming years.

Historically, Kent Lake has avoided shareholder activism. However, we believe the Merger with Akoya would cause irreparable harm to Quanterix stockholders and cannot allow it to proceed without voicing our concerns.